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Topical antiaging products are often a first-line intervention to counter visible signs of
facial photoaging, aiming for sustained cosmetic improvement. However, prolonged
application of a single active topical compound was observed clinically to lead to a
plateau effect in improving facial photoaging. In view of this, we set out to reduce this
effect systematically using a multi-tiered approach with laboratory evidence and clinical
trials. The objective of the study was to evaluate the effects of active topical ingredients
applied either alone, in combination, or in a rotational manner on modulation of facial
photoaging. The study methodology included in vitro, organotypic, and ex vivo skin
explants; in vivo biopsy study; as well as clinical trials. We demonstrate for the first
time that a pair of known antiaging ingredients applied rotationally, on human dermal
fibroblasts, maximized pro-collagen I production. Indeed, rotational treatment with retinol
and phytol/glycolic acid (PGA) resulted in better efficacy than application of each active
ingredient alone as shown by explants and in vivo biopsy study, with penetration of active
ingredients confirmed by Raman spectroscopy. Furthermore, two split-face, randomized,
double-blinded clinical trials were conducted, one for 12 months to compare treated vs.
untreated and the other for 6 months followed by a 2-month regression to compare
treated vs. commercially marketed products. In both studies, rotational regimen showed
superior results to its matching comparison as assessed by clinical grading and image
analysis of crow’s feet wrinkles. In conclusion, rotational regimen using retinol and PGA
is effective in treating facial photoaging signs with long-lasting benefits.
Keywords: rotational combination regimen, skin cosmetics, skin topical application, facial photoaging, cosmetic
dermatology
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INTRODUCTION
Chronic sun exposure, pollution, and intrinsic aging can add
wrinkles and age spots to the facial skin (1–6). With consumers
desiring healthier and younger-looking skin, there is a high
demand for effective topical anti-aging cosmetic treatments
with long-lasting results. Active ingredients such as alpha-
hydroxy acids, antioxidants, and retinol can boost collagen
production and diminish the appearance of wrinkles (7–11).
Among these, retinol is recognized as one of the most effective
(12, 13). However, there are limitations and certain side effects
associated with continued use of retinol products alone (14). In
addition, our clinical observations (n = 32) demonstrated that
prolonged application of a single active ingredient led to a plateau
effect in improving facial photoaging (Figure 1). Furthermore,
feedback from consumers (own unpublished data) showed that,
after using products for a few months, there appears to be
a “plateau effect” in which the product stops improving their
skin and signs of photoaging. Another efficacious ingredient
with known mechanism of action complementary to retinol is
glycolic acid (15). Combining them together could potentially
lead to better rate of improvements. However, combining these
two topicals can be challenging due to formulation requirements
(unpublished own data). An alternative approach of maximizing
retinol efficacy could be by using a phytanic acid precursor,
phytol, which has a mechanism of action similar to retinol and
complements it by barrier protecting properties.
In view of the above, we set out to address this issue
systematically (Figure 2). We examined the effect of previously
proven single active ingredients using two different model
systems, discussed below. These experiments confirmed that
there was a plateau effect in response to a single active ingredient
in isolation. Thus, we conducted a series of experiments to assess
the effects of varying application regimens of active ingredients
on the production of dermal matrix components using human
dermal fibroblasts in vitro and 3-dimensional (3D) organotypic
skin models. Ingredients were tested alone, in combination,
and in a rotational manner. These experiments identified that
FIGURE 1 | The effect of retinol on clinical efficacy rate of improvements. A significant (p < 0.05) improvement in both coarse wrinkles and discrete pigmentation was
observed as early as 4 weeks, but the rate of improvement achieved over a given time interval decreased as the study progressed. *Means p < 0.05 or statistically
significant result.
ingredients applied in rotation for a period of time resulted in
greater pro-collagen I production compared with the continuous
application of either ingredient alone for the same period of
time. The results were further solidified with evidence from
an ex vivo skin model using whole human skin organ culture
and in vivo human volunteer biopsy studies. In addition, using
Raman spectroscopy (RS), we confirmed penetration of the active
ingredients and demonstrated structural changes in the skin
following application of the active ingredients in each layer of
the skin.
Finally, two split-face, randomized, institutional review board
(IRB)-approved, double-blinded clinical trials were conducted
to compare the efficacy of this novel rotational regimen vs. an
untreated condition. Treatments were also compared against
commercially comparable marketed products.
MATERIALS AND METHODS
In vitro Study Using Cultured Human
Dermal Fibroblast Cells
Human dermal fibroblast cells were grown in a six-well plate
in Dulbecco’s Modified Eagle Medium (DMEM) (Corning,
USA) supplemented with 10% fetal bovine serum (FBS)
and L-glutamine (1.5 × 105 cells/plate). After reaching
about 75% confluence, cells were transferred into DMEM
without FBS and incubated for 4–6 h. Next, cells were
treated with given active ingredients in DMEM without
FBS. Media were collected and treatment was repeated every
48 h. Cells were either treated with a single ingredient over
the entire course of treatment, treated with a combination
of ingredients, or treated with one ingredient for 6 days
followed by treatment with alternative ingredients for the
remaining time. After treatment, conditioned media were
collected, and the amount of collagen and hyaluronic acid
secreted was tested in the media using Homogeneous Time
Resolved Fluorescence (HTRF) human pro-collagen I or
hyaluronic acid binding protein assay kit (Cisbio Inc., Bedford,
MA, USA).
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FIGURE 2 | Study methodological flowchart. This flowchart represents the summary of laboratory and clinical testing conducted with the novel rotational regimen.
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FIGURE 3 | Study details of clinical trial #2 (A) and #3 (B).
FIGURE 4 | The effect of phytol on pro-collagen I, hyaluronic acid (HA) production in human dermal fibroblasts, and nuclear factor kappa-light-chain-enhancer of
activated B cells (NFκB) phosphorylation in human epidermal keratinocytes. Phytol increased the levels of pro-collagen-I (A) and hyaluronic acid (B) in human primary
dermal fibroblasts following 48-h treatment (p < 0.05). (C) Phytol reduced the levels of phosphorylated NFκB in tumor necrosis factor α (TNFα)-treated human primary
keratinocytes in a dose-dependent manner (p < 0.05). The assays were performed in triplicate for each sample, and the values represent mean ± SD (standard
deviation). *Means p < 0.05 or statistically significant result.
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Phytol Inhibition of Tumor Necrosis Factor
α-Induced NFKB Phosphorylation Assay
Human epidermal keratinocytes were grown in six-well plates
(n = 3 for each treatment). The next day, cells were pretreated
with phytol for 24 h. After the pretreatment, 100 ng/ml tumor
necrosis factor (TNFα) was added for 5min to induce the nuclear
factor kappa-light-chain-enhancer of activated B cells (NFκB)
pathway. After treatment, cells were washed with phosphate-
buffered saline (PBS), and lysis buffer was added directly to cells
followed by freezing at −80◦C. Cell lysates were normalized
to the same protein concentration, and NFκB phosphoS536
was measured using HTRF technology (Cisbio Inc., Bedford,
MA, USA).
Gene Expression Analysis
Sixteen Caucasian post-menopausal female subjects between
55 and 65 years of age with skin types II–III were recruited
for the study. The dorsal forearms of the subjects were patch
treated with either 0.01% retinoic acid (RA) or 0.1% retinol
(daily for the first 5 days, alternate days subsequently). On days
4, 8, 15, and 30, 3-mm punch biopsies were taken from the
treated and adjacent untreated areas (with approval of an IRB
and informed consent of the subjects). RNA from the biopsy
samples were isolated using the RNeasy method (Qiagen, UK).
RNA samples were converted into labeled target antisense RNA
(cRNA) using the Single-round RNA amplification and biotin
labeling system (Enzo). The resulting cRNA is fragmented and
applied to Human U133 Plus 2.0 arrays. Following hybridization,
arrays were washed and stained using standard Affymetrix
procedures before scanning on the Affymetrix GeneChip Scanner
and data extraction using Expression Console. Pathway analysis
was conducted using Ingenuity Systems (Qiagen, Redwood
City, USA).













Results are shown as up-down regulation compared to control group. Phytol significantly
(p < 0.05) increased gene expression of Fibronectin 1 (FN1), Kallikrein-6 (KLK6), Heparin-
Binding Epidermal Growth Factor-Like Growth Factor (HBEFG), Tenascin C (TNC), Loricrin
(LOR), Arachidonate 12-lipoxygenase B (ALOX12B), Hyaluronan synthase 3 (HAS3),
and Arachidonate 12-lipoxygenase (ALOX12). Phytol significantly (p < 0.05) decreased
the gene expression of prostaglandin-endoperoxide synthase 2 (PTGS2) and matrix
metalloproteinase-3 (MMP3).
3D Organotypic Tissues and ex vivo
Studies
3D skin model EPI200 (MatTek, Ashland, USA) was maintained
in media supplied by manufacturer. Onto the surface of tissues,
1% phytol was applied in five replicates. After 24 h of treatment,
tissues were rinsed and fresh treatment was added for additional
24 h, for total of 48-h incubation. After treatment, tissues were
rinsed and frozen in liquid nitrogen for RNA isolation. RNA
was extracted from tissues using TRIzol reagent (Thermo Fisher
Scientific Inc., Waltham, USA). Total RNA was used for cDNA
synthesis using RT2 First Strand Kit (Qiagen; Valencia, USA). The
expression of genes highly relevant to skin biology was analyzed
using custom-designed RT2 Profiler PCR Array (Qiagen, UK).
Ex vivo analysis was performed on surgically removed skin
with written informed consent and with ethical and institutional
approval from the University of Manchester (ethics reference:
11/NW/0683). All tissues were tracked and stored in a human
tissue biobank following guidelines set by the Human Tissue Act.
To a 24-well plate containing trans-well inserts, 6-mm punch
biopsies of skin were added, allowing the biopsy to be suspended
in liquid culture media while keeping the epidermis separate
and exposed to air for the addition of treatments. To each well,
500 µl of supplemented serum-free William’s E culture media
(1% penicillin/streptomycin, 1% L-glutamine, 1% non-essential
amino acid solution, 1% ITS+3, and 10 ng/ml hydrocortisone)
was added and changed daily. Antibiotics were used in order to
prevent contamination by the microflora naturally present on
human skin. The culture model was maintained in an incubator
under standard conditions (37◦C, 5% CO2). Skin explants
were treated with two formulations, one containing retinol and
one phytol/glycolic-based, either alone or in sequence rotation.
Treatments were repeated daily for 12 days. For continuous
treatment, samples were treated with a formulation containing
either 0.1% retinol or 4% glycolic acid and 1% phytol alone. For
rotational treatment, samples were treated with a formulation
containing 4% glycolic acid and 1% phytol for 3 days, followed
by a formulation containing 0.1% retinol for 3 days, with a
total of two rotation cycles. After treatment, samples were fixed
in formalin and processed for histological analysis following
standard protocol.
In vivo Biopsy Collection
The study was conducted at Product Investigations, Inc.
(Conshohocken, USA) following a standard protocol. Briefly,
Caucasian female (n = 32) subjects between 21 and 70 years
of age participated in an application regimen over a 4-week
period. The lower volar arms of subjects were treated with test
articles for 4 weeks under patch. Treatments were repeated daily
and remained under patch over the weekend. For continuous
treatment, subjects were treated with a formulation containing
either 0.1% retinol or 4% glycolic acid and 1% phytol (PGA). For
“rotational” treatment, subjects were treated with a formulation
containing PGA on weeks 1 and 3, while a formulation
containing 0.1% retinol was used on weeks 2 and 4. After the
treatment, a sample of the skin was obtained via biopsy (2mm)
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from each of the test/control sites. Skin samples were analyzed by
histology and Raman spectroscopy.
Histological Analysis
The skin samples were fixed in 10% formalin. Next, samples
were sequentially dehydrated in 70, 95, and 100% ethanol; cleared
in xylene; and embedded in paraffin. Following this, 6-µm
sections were obtained using a microtome and processed for
histological analyses. Hematoxylin and eosin (H&E) staining
was performed as per standard H&E protocol, and slides
were scanned by 3DHistech Pannoramic-250 microscope slide
scanner. Three measurements of the cellular portion of the
epidermal compartment were performed using CaseViewer2.2.
Subsequently, immunohistochemistry was conducted according
to the following: sections were dewaxed in xylene followed
by rehydration. Then, heat-induced antigen retrieval was
performed with sections incubated in pre-boiled citrate buffer
(pH 6.0 × 10) in a microwavable vessel at 80-W power for
20min then cooled for 30min at room temperature. Following
incubation in BLOXALL Endogenous Peroxidase and Alkaline
Phosphatase Blocking Solution (Vector Laboratories, UK) for
10min. Sections were incubated with biotinylated hyaluronic
FIGURE 5 | Efficacy rate evaluation. (A) The effect of retinol and phytol on pro-collagen I synthesis in human dermal fibroblast cells. Human dermal fibroblasts were
treated with 0.0001% phytol or 0.00003% retinol for a period of 16 days, and production of pro-collagen I was measured. The assay was performed in triplicate for
each sample, and the values represent mean ± SD. Stimulation of pro-collagen I synthesis was observed with both active ingredients (p < 0.05), but the rate of
improvements decreased over time. (B) The effect of retinoic acid on gene expression in human skin. A formulation containing 0.02% retinoic acid was applied under
occlusion on the lower dorsal arm. Subjects were treated daily for the first 5 days followed by treatment on alternate days for a total of 30 days. Skin samples were
collected by punch biopsy on days 4, 8, 15, and 30. RNA was extracted, and whole genome expression was analyzed by Human U133 Plus 2.0 arrays. Retinoic acid
treatment resulted in upregulation of Kallikrein-6 (KLK6), Sterile alpha motif domain-containing protein 9 (SAMD9), Amphiregulin (AREG), and Psoriasin (S100A) genes,
which peaked on days 4–8, p < 0.05. (C) The effect of retinol on dermatitis-associated genes in human skin. A formulation containing 0.1% retinol was applied under
occlusion on the lower dorsal arm. Subjects were treated daily for the first 5 days followed by treatment on alternate days for a total of 30 days. Skin samples were
collected by punch biopsy on days 4, 8, 15, and 30. RNA was extracted, and whole genome expression was analyzed by Human U133 Plus 2.0 arrays. Pathway
analysis performed using Ingenuity Pathway Analyses (IPA) showed that there was an increase in the number of dermatitis-associated genes after continued retinol
treatment detectable at day 15.
TABLE 2 | The effect of active ingredient application on pro-collagen I in human dermal fibroblasts in vitro.
Ingredient A Ingredient B A B A+B combined A/B rotation B/A rotation
% change in pro-collagen I production
Phytol 0.0001% Retinol 0.00003% 19.1 3.9 7.09 75.7* 92.6*
Rotational treatment led to a significant (p < 0.05) increase in pro-collagen I production compared to other treatments.
*Means p < 0.05 or statistically significant result.
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FIGURE 6 | The effect of rotational treatment on epidermal thickness in skin explants ex vivo. Skin explants (n = 5) were treated (in triplicate) with continuous
application of a single formula for 12 days or with two rounds of rotational application of each formula (per 3 days). Epidermal thickness was assessed by hematoxylin
and eosin (H&E). All treatments increased epidermal thickness when compared to a placebo (p < 0.05), while rotational treatment was significantly better than retinol
formula alone. i: untreated, ii: placebo for retinol, iii: retinol, iv: placebo for 1% phytol/4% glycolic acid (PGA), v: PGA, vi: placebo for vii, and vii: rotation of iii and v.
Scale bar = 100µm. *Means p < 0.05 or statistically significant result.
FIGURE 7 | Histology of skin biopsies. Volunteers (n = 32) received application of either 0.1% retinol formulation for 4 weeks or weekly rotation of 1% phytol/4%
glycolic acid (PGA) formula with 0.1% retinol formula. Biopsy samples were taken at the end of the 4-week period. An analysis of epidermal thickness in in vivo skin
samples by H&E staining showed that retinol and rotational formulations have a significant effect on increasing epidermal thickness when compared to placebo (p <
0.05). i: untreated, ii: placebo for retinol, iii: retinol, iv: placebo for PGA, v: PGA, vi: placebo for vii, and vii: rotation of iii and v. Scale bar = 50µm. *Means p < 0.05 or
statistically significant result.
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FIGURE 8 | Immunohistology of skin biopsies. Volunteers (n = 32) received application of either 0.1% retinol formulation for 4 weeks or weekly rotation of 1%
phytol/4% glycolic acid (PGA) formula with 0.1% retinol formula. Biopsy samples were taken at the end of the 4-week period. An analysis of epidermal hyaluronic acid
in in vivo skin samples via HABP staining was performed. Rotational treatment was superior to retinol alone and better than the PGA formula (p < 0.05). i: untreated, ii:
placebo for retinol, iii: retinol, iv: placebo for PGA, v: PGA, vi: placebo for vii, and vii: rotation of iii and v. Scale bar = 50µm. *Means p < 0.05 or statistically
significant result.
FIGURE 9 | Immunohistology of skin biopsies. Volunteers (n = 32) received application of either 0.1% retinol formulation for 4 weeks or weekly rotation of 1%
phytol/4% glycolic acid (PGA) formula with 0.1% retinol formula. Biopsy samples were taken at the end of the 4-week period. An analysis of pro-Collagen I in in vivo
skin samples using pro-collagen I antibody was performed. Pro-collagen I production increased significantly in rotational treatment and was better than retinol alone. i:
untreated, ii: placebo for retinol, iii: retinol, iv: placebo for PGA, v: PGA, vi: placebo for vii, and vii: rotation of iii and v. Scale bar = 50µm. *Means p < 0.05 or
statistically significant result.
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FIGURE 10 | Immunohistology of skin biopsies. Volunteers (n = 32) received application of either 0.1% retinol formulation for 4 weeks or weekly rotation of 1%
phytol/4% glycolic acid (PGA) formula with 0.1% retinol formula. Biopsy samples were taken at the end of the 4-week period. An analysis of Col III/I ratio in in vivo skin
samples using Herovici staining was performed to differentiate mature collagen (type I) (pink/red) and immature collagen (type III) (blue). All treatments led to increase in
collagen III and improved the ratio of collagen III/I. i: untreated, ii: placebo for retinol, iii: retinol, iv: placebo for PGA, v: PGA, vi: placebo for vii, and vii: rotation of iii and
v. *Scale bar = 100µm.
acid-binding protein (HABP) (MERCK cat 385911) antibody at
0.5µg/ml in DAKO antibody diluent (S0809) overnight at 4◦C.
After incubation with an AP detection system (VECTASTAIN
ABC-AP Staining Kit VECTOR AK 5000) for 30min, sections
were rinsed well with PBS, then incubated with Vector Blue
Alkaline Phosphatase Substrate (VECTOR SK5300) for 20min.
The reaction was completed, and slides were mounted with
an aqueous mount medium. For Herovici staining, the slides
were incubated in Van Gieson stain solution (50% Van Gieson
solution, Sigma HT254-250ML; 0.025% methyl blue, Sigma cat
M44907; 10% glycerol, Fisher Chemical cat G/0650/08; and
0.5% lithium carbonate, Fluka cat 62472) for 10min, then
differentiated in 1% acetic acid for 30 s, dehydrated through
alcohol and xylene, andmounted. The sections were scanned and
analyzed using Definiens Tissue Studio software, version 64.4.0
(Definiens, Munich, Germany) and MATLAB software.
Raman Spectroscopy
Skin biopsies of 2-mm diameter were snap frozen, cut
into 10-µm cross-sections, and placed onto Raman-grade
calcium fluoride slides (Crystran Ltd, UK). The cross-sections
were analyzed on a Renishaw inVia Raman microscope
(Renishaw, UK), using an optimal wavelength of 785 nm.
Samples were visualized and each dermal layer identified
(epidermis, papillary, and reticular dermis). Three static
spectral point measurements were taken in each layer using
WiRE (Windows-based Raman Environment; Renishaw, UK).
Optimized conditions required 100% laser power, for 10-s
exposure time and 20 accumulations (a total measurement
time of 200 s per point); prior to each measurement, a depth
series acquisition was undertaken to ensure the sample
was flat and to optimize penetration depth. After acquiring
each measurement, cosmic ray removal was performed.
Data analysis was undertaken in MATLAB (MathWorks,




Eligible women aged 35–72 years in good health (neither
pregnant nor lactating as assessed via questionnaire) were
recruited and selected. Subjects were skin types I–IV who
presented mild to moderate signs of photodamage (wrinkles,
hyperpigmentation, and lack of radiance) on both sides of
their faces and scored 3–6 to qualify on a 0–9 scale (modified
Griffiths scale 0–9: 0 = none, 1–3 = mild, 4–6 = moderate, and
7–9= severe).
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FIGURE 11 | Raman spectroscopy analysis of in vivo skin samples. Volunteers (n = 32) received application of either 0.1% retinol formulation for 4 weeks or weekly
rotation of 1% phytol/4% glycolic acid (PGA) formula with 0.1% retinol formula. Biopsy samples were taken at the end of the 4-week period, and samples were
analyzed by confocal Raman. (A) Graphs represent the average spectra for all papillary dermis. Key peaks relating to collagen/protein content are labeled as described
in the text. (B) Bar charts indicating key peaks. (i) The bandwidth 1,451 cm−1 represents the CH bending mode of collagen; data collected at this bandwidth was
normalized to phenylalanine (Phe) peak at 1,002 cm−1. The average band intensity at 1,451 cm−1 for untreated, retinol-treated, and rotational-treated samples in the
papillary (-P) and reticular (-R) layers is plotted. As the dataset was parametric, a t-test was used to demonstrate that there was a significant increase at this
bandwidth in untreated samples compared to rotational in the reticular layer. *p < 0.05. (ii) The band area ratio 938/932 cm−1 calculated in untreated, retinol-treated,
and rotational-treated samples in the papillary (-P) and reticular (-R) layers accounting for proline and hydroxyproline residues of collagen and water, indicating collagen
hydration status. All data were standardized to Phe (1,002 cm−1). The ratios 938/932 cm−1 were tested by one-way ANOVA and then t-test was used to evaluate
significance (rotational papillary samples significantly greater than untreated). *p < 0.05. (iii) The bandwidth 1,160 cm−1 represents glycosaminoglycan (GAG) content;
data collected at this bandwidth was normalized to Phe peak at 1,002 cm−1. The average band intensity at 1,160 cm−1 for untreated, retinol-treated, and
rotational-treated samples in the papillary (-P) and reticular (-R) layers is plotted. As the dataset was parametric, a t-test was used to demonstrate that there was a
significant increase at this bandwidth in rotational papillary samples compared to untreated samples. *p < 0.05. (iv) The band area 1,246/1,271 cm−1 ratio calculated
in untreated, retinol-treated, and rotational-treated samples in the papillary (-P) and reticular (-R) layers demonstrating the proline poor/proline rich ratio of collagen.
The ratios 1,246/1,271 cm−1 were tested by one-way ANOVA, and although the trend indicates a higher ratio in retinol and rotational samples in both layers
compared to untreated samples, this was not significant, when compared using a t-test. Data are standardized to Phe (1,002 cm−1). (v) The band area ratio
1,655/1,446 cm−1 was calculated in untreated, retinol-treated, and rotational-treated samples in the papillary (-P) and reticular (-R) layers and has also been shown to
demonstrate collagen content. The ratios 1,655/1,446 cm−1 were tested by one-way ANOVA, and then a t-test was used to evaluate significance; rotational samples
in the reticular layer had a statistically significant increase in band area ratio compared to untreated samples. Data are standardized to Phe (1,002 cm−1). *p < 0.05.
Trial Design
Clinical studies were divided into three independent trials. The
first trial was conducted to assess the rate of improvement
after retinol treatment. The second trial assessed the efficacy of
rotational treatment over 1-year period. The third trial compared
the rotational treatment formulation to two commercially
available antiaging products. Trial details can be found in the
CONSORT flowchart (Figure 3).
The first trial was conducted on 32 healthy females aged 35–59
who were enrolled with moderate (grades 3–6) wrinkles. Subjects
had mild to moderate grades for other signs of photodamage.
The second trial was conducted in 116 healthy female volunteers,
aged 35–72, for 12 months. The subjects were randomized and
assigned to use the regimen on the left or right side of their faces
with the other side untreated. The third study was conducted in
144 healthy female volunteers with 6 months of product usage
followed by a 2-month regression period. All clinical trials were
conducted at Stephens & Associates in Texas and received IRB
approval by IntegReview IRB. Subjects were randomized and
assigned to the regimen on the left or right side of their faces. In
the third study, subjects were randomized into one of two groups
at the baseline visit. Group 1 subjects used the rotational products
on one side of their faces and used a commercial product on the
other side. In group 2, subjects used the rotational products on
one side of their faces and used a different commercial product
on the other side. Study participants gave a written informed
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consent. Trials followed the Declaration of Helsinki and were
registered with ISRCTN (ISRCTN17303898, May 2020).
In the first study, subjects applied 0.1% retinol to their faces
once daily for 12 weeks; a standard cleanser and sunscreen were
provided. A dermatologist evaluated subjects’ skin condition at
baseline and after 4, 8, and 12 weeks. In the second study,
at the baseline visit, eligible subjects were randomized to use
the rotational product [alternating weekly between treatment A
(PGA) and treatment B (containing retinol)] on the left or right
side of the face, with the other side of the face untreated. Subjects
returned to the clinic at weeks 4, 8, 12, 18, 24, 36, and 52 for
clinical evaluation and digital imaging procedures. In the third
study, subjects were randomized into one of two groups at the
baseline visit. Group 1 subjects used the rotational products on
one side of their faces and used a commercial product (C) on the
other side. In group 2, subjects used the rotational products on
one side of their faces and used a commercial product (D) on the
other side. Clinical evaluations and digital imaging procedures
were conducted at baseline and weeks 2, 4, 8, 12, 18, 24, and 32.
Trial Assessment
Clinical evaluations on facial photoaging signs were done by
trained clinical evaluators using a modified Griffiths scale (0–
9: 0 = none, 1–3 = mild, 4–6 = moderate, and 7–9 = severe)
(16). The following parameters were evaluated for each side of
the face: fine lines and coarse wrinkles (global face and crow’s
feet area), hyperpigmentation, skin tone (color) evenness, tactile
texture, visual texture, clarity, radiance, firmness (tactile), and
sagging. Safety assessment on tolerability was assessed on a 0–
3 scale (0 = none, 1 = mild, 2 = moderate, and 3 = severe)
for erythema, dryness, edema, burning, itching, and stinging.
Digital photographs were taken using a photo station with a
Nikon D7000 digital SLR camera under raking light, cross-
polarized light, and visible light. Crow’s feet wrinkles and lines
were quantified using the SWIRL method (17).
Statistical Analysis
The software used was SAS version 9.4 (SAS Institute, Care, NC,
USA). Clinical grade and image data for treated sides of the
face, adjusted for the untreated side, were analyzed by ANOVA
(treated–untreated) or ANCOVA (untreated as covariate) for
clinical study 1 and, where appropriate, Tukey’s test was used to
compare group means. A two-tailed significance level of α = 0.05
was used for all statistical comparisons. Raman spectroscopy data
was tested by a one-way ANOVA. The data were parametric, and
therefore t-test was used for assessment of statistical significance.
RESULTS
Efficacy of a Single Active Ingredient
Plateaus Over Time
Retinol and glycolic acid are widely accepted as efficacious
antiaging ingredients (15, 18), while phytol shows strong potency
in vitro on induction of dermal matrix components, such as
pro-collagen I and hyaluronic acid (HA) inhibition of pro-
inflammatory signaling (NFκB) (Figure 4), and modulation of
genes related to epidermal turnover, skin barrier, inflammation,
and matrix remodeling (Table 1). When skin cells are exposed to
retinol or phytol, both ingredients are converted to their bioactive
forms, namely, retinoic acid and phytanic acid, which are known
to bind to their respective receptors and induce downstream
signaling (19, 20). Human dermal fibroblasts were treated with
0.0001% phytol or 0.00003% retinol for an extended period (16
days), and production of pro-collagen I, a marker of antiaging
that correlates with improvements in wrinkles (21, 22), was
measured (21, 22). Stimulation of pro-collagen I synthesis with
both active ingredients decreased over time and the effect leveled
off (Figure 5A).
Next, we investigated the rate of retinol efficacy by gene
expression analysis using an in vivo human volunteer biopsy
study (n = 16). After treatment with formulations containing
0.02% retinoic acid or 0.1% retinol, 2-mm punch biopsies were
taken on days 4, 8, 15, and 30 from the volunteers’ forearms.
Volunteers were treated daily for the first 5 days followed
by treatment on alternate days for a total of 30 days. Whole
genome expression microarray analysis (Human U133 Plus
2.0 arrays) demonstrated upregulation of several retinoic acid-
induced genes (such as KLK6, SAMD9, AREG, and S100A),
which peaked on days 4–8 (p < 0.05), then leveled off over time
(Figure 5B), confirming our initial observation of the plateau
effect from the in vitro experiment. Furthermore, Ingenuity
Pathway Analyses (IPA) of the retinol gene array data showed
that there was an increase in the number of dermatitis-associated
genes over time after continued retinol treatment. IPA analysis
demonstrated collective gene expression changes with an increase
in dermatitis on days 15 and 30 (Figure 5C). Taken together,
these results further emphasize the suboptimal response of
using one active ingredient in isolation over a continued period
of time.
Rotational Application of Active
Ingredients in vitro Enhances Efficacy
Thus, it was hypothesized that the observed plateau effect could
be prevented by “rotational” application of active ingredients that
would lead to stimulation of different biological pathways in skin.
Human dermal fibroblasts were treated with either phytol or
retinol continuously for 12 days, a combination of both, or in
rotation (6 days of treatment with phytol followed by 6 days of
treatment with retinol). Rotational treatment led to an increase
in pro-collagen I production (p< 0.05) compared to either of the
active ingredients alone (Table 2). In view of this, we focused our
attention on a rotational regimen of these two active ingredients.
In addition, in order to gain maximum clinical efficacy, we
combined phytol with glycolic acid.
Ex vivo Analysis of Rotational Regimen
Demonstrates Enhanced Efficacy
Topical application of formulas containing 0.1% retinol or 1%
phytol formulated with 4% glycolic acid (PGA) was assessed on
ex vivo skin samples (n= 5). H&E staining (Figure 6) evaluation
showed a significant effect of all formulations (p < 0.01) on
increasing epidermal thickness when compared to a placebo.
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Mean 58.7 ± 8.0
Ethnicity
Hispanic or Latino 17 (13.1)
Not Hispanic or Latino 113 (86.9)
Race
American Indian or Alaska Native 1 (0.8)
Asian 16 (12.2)










Lost to follow-up 2
ITT, Intend-to-Treat; PP, Per Protocol.
Interestingly, rotational treatment was comparable to PGA and
significantly better than retinol formula alone.
In vivo Histological Analysis of
Phytol/Glycolic Acid and Retinol Confirms
the Role of Rotational Application
Formulations were applied to volunteers’ (n = 32) volar
forearm skin under occlusive patch for 4 weeks in a continuous
vs. rotational manner. Skin biopsies (2mm) were analyzed
by histology. H&E staining (Figure 7) evaluation showed a
significant effect (p< 0.01) of retinol and rotational formulations
on increasing epidermal thickness when compared to placebo.
Of note, rotational treatment was comparable to retinol alone
but significantly better (p < 0.05) than the PGA formulation.
Evaluation of epidermal hyaluronic acid (HA) level using
HABP staining (Figure 8) showed an increased expression
level of HABP in the epidermal layer after treatment with
all formulations, indicative of an increase in HA. Rotational
treatment was superior to retinol alone (144.76 vs. 29.07%
increase, p < 0.05) and better than the PGA formula (106.47%
increase, p < 0.05). Pro-collagen I was also assessed in vivo
(Figure 9). Pro-collagen I production increased (p < 0.05) in
rotational treatment and was significantly better than retinol
alone (46.27 vs. 8.92%). Finally, we analyzed the ratio of
collagen I and III, in the biopsy samples using Herovici staining
FIGURE 12 | Clinical trial #2 results. (A) Dermatological evaluation of 1-year clinical efficacy results. Clinical grading results show reduction (improvement) in
photoaging parameters at different timepoints over a 1-year period when compared to baseline scores (*p < 0.05). Statistical significance was achieved for most
parameters at week 4 and for all parameters starting from week 8. Note that the improvement was gradual and continuous over the course of the year. (B) Image
analysis of 1-year clinical efficacy results on crow’s feet wrinkles. Image analysis shows reduction (improvement) in wrinkle parameters at the crow’s feet area at
different timepoints over a 1-year period when compared to baseline values (*p < 0.05). Note that the untreated side showed worsening over time.
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FIGURE 13 | Clinical trial #2 results. (Ci) Month-to-month significant improvement in dermatological grading up to 1 year. Dermatological grading shows statistically
significant improvement (p < 0.05) in global crow’s feet coarse wrinkle parameters. Bar color changes month-to-month indicates statistical improvement from
previous timepoint. This pattern of improvements noted throughout the year are an indication the plateau effect can be overcome with this specific rotational
formulation. (Cii) Month-to-month significant improvement in dermatological grading up to 1 year. Dermatological grading shows statistically significant improvement (p
< 0.05) in mottled and discrete hyperpigmentation parameters. Bar color changes month to month indicates statistical improvement from previous timepoint. This
pattern of improvements noted throughout the year are an indication the plateau effect can be overcome with this specific rotational formulation. (Ciii) Month-to-month
significant improvement in dermatological grading up to 1 year. Dermatological grading shows statistically significant improvement (p < 0.05) in global fine and crow’s
feet wrinkle parameters. Bar color changes month to month indicates statistical improvement from previous timepoint. This pattern of improvements noted throughout
the year are an indication the plateau effect can be overcome with this specific rotational formulation. (Civ) Month-to-month significant improvement in dermatological
grading up to 1 year. Dermatological grading shows statistically significant improvement (p < 0.05) in skin tone evenness parameter. Bar color changes month to
month indicates statistical improvement from previous timepoint. This pattern of improvements noted throughout the year are an indication the plateau effect can be
overcome with this specific rotational formulation. (Cv) Month-to-month significant improvement in dermatological grading up to 1 year. Dermatological grading shows
statistically significant improvement (p < 0.05) in tactile firmness and global sagging parameters. Bar color changes month to month indicates statistical improvement
from previous timepoint. This pattern of improvements noted throughout the year are an indication the plateau effect can be overcome with this specific rotational
formulation. (Cvi) Month-to-month significant improvement in dermatological grading up to 1 year. Dermatological grading shows statistically significant improvement
(p < 0.05) in global clarity and tactical texture parameters. Bar color changes month to month indicates statistical improvement from previous timepoint. This pattern
of improvements noted throughout the year are an indication the plateau effect can be overcome with this specific rotational formulation.
(Figure 10). All three treatments increased collagen III (p< 0.05)
levels significantly, resulting in an increase in collagen III/I ratio.
Raman Spectroscopy Analysis Shows
Active Penetration and Structural Dermal
Changes
Raman spectroscopy analysis confirmed delivery of treatment
active ingredients within the dermis and treatment effects using
previously evidenced key peaks in skin biopsies. Figure 11A
demonstrates the spectra exhibited through the papillary layer
in untreated, retinol-treated, and rotational-treated skin. Some
of the bands where the rotational samples have the highest
attenuation are highlighted, representing lipids, collagen, and
residues of collagen. The band at 1,236 cm−1 is well-known
to represent amide III, and peaks at 1,271 cm−1 are also part
of the amide III band but more specifically for proline and
hydroxyproline residues of collagen. The peaks at 1,468 and 1,477
cm−1 may represent the amide II band. In Figure 11B (i), the
band at 1,451 cm−1 (the CH bending mode of collagen) was
significantly altered throughout untreated samples, compared
to rotational treatment (p = 0.037). In Figure 11B (ii), the
938:922 cm−1 ratio, representing proline and hydroxyproline
residues of collagen and water molecules, was significantly
increased (p = 0.03) in rotational treatment compared to
untreated samples in the papillary layer, indicating an increase
in collagen hydration status. The glycosaminoglycan (GAG)
content assessed at 1,160 cm−1 was increased in both treated
conditions, with a significantly higher increase (p= 0.022) in the
rotational samples in the papillary layer (Figure 11B, iii). The
proline poor/proline rich ratio 1,246:1,271 cm−1 (Figure 11B,
iv) demonstrated an increase in retinol and rotational samples
compared to untreated samples, although this trend was
not significant. The 1,655:1,446 cm−1 ratio (Figure 11B, v),
representing collagen content, was significantly greater in
rotational compared to untreated samples in the reticular
dermis (p= 0.035).
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TABLE 4 | Demographic information on clinical trial #3.
Group 1: rotational product vs. product C Group 2: rotational product vs. product D
N 83 81
Age (years)
Mean 58.9 ± 8.2 59.6 ± 7.1
Ethnicity
Hispanic or Latino 4 (4.8) 6 (7.4)
Not Hispanic or Latino 79 (95.2) 75 (92.6)
Race
American Indian or Alaska Native 0 (0.0) 1 (1.2)
Asian 11 (13.3) 4 (4.9)
Black or African American 7 (8.4) 12 (14.9)
White 64 (77.1) 63 (77.8)
Multiracial 1 (1.2) 1 (1.2)
ITT population 83 81
Completed subjects (PP population) 74 70
Discontinued subjects 9 11
Reason for discontinuation
Adverse event 1 5
Subject requested withdrawal 4 2
Non-compliance 0 2
Investigator decision 1 1
Lost to follow-up 3 1
ITT, Intend-to-Treat; PP, Per Protocol.
Clinical Efficacy Trial of Rotational
Treatment Exhibited Incrementally
Significant Efficacy Throughout the Year
The second clinical trial was designed to evaluate the efficacy
of the rotational skin care regimen for 1 year to determine if
this regimen would deliver continued improvement over the
course of the year. A total of 116 female subjects completed
the trial (Table 3). Clinical evaluation by expert graders showed
that treatment with the rotational regimen resulted in statistically
significant improvement in all photoaging parameters after as
few as 4 weeks of product usage (Figure 12A). The improvement
was continuous throughout the course of the year, with 10–
40% subjects showing improvement of various parameters at
week 4 and up to 90–100% subjects showing improvement in
all parameters at year end. The mean percentage change of the
whole population also increased from 1–5% at week 4 to 15–
25% at year end. The untreated side of the face showed minimal
improvement, with hyperpigmentation getting worse (with a
mean change of 1–2% on key photoaging parameters: coarse
wrinkles and hyperpigmentation). Image analysis of crow’s feet
wrinkles/lines provided objective and quantitative assessment
to support the clinical findings (17). Wrinkle condition in the
crow’s feet area was quantified for wrinkle count, length, width,
perceived depth, and area (Figure 12B). All parameters showed
statistically significant improvement (p < 0.05) on treated side
with rotational regimen and no improvement or worsening
on untreated side. In addition, most parameters exhibited
statistically significant improvement between each consecutive
timepoint evaluated (Figure 13, ci–vi).
Clinical Efficacy Trial of Rotational
Treatment Was Significantly Better Than
Similar Antiaging Products
The third trial was designed to compare rotational combination
regimen against competitive products. Two products were
chosen: one with retinol alone (product C) and one with
antioxidant and peptides purported to boost collagen production
(product D). A total of 144 subjects completed the third clinical
trial. Subjects were randomized into two groups, 1 and 2.
Both groups used the rotational regimen alongside either of
the marketed products, C (those in group 1) or D (group 2).
Demographic information is listed in Table 4.
All products produced significant improvement on various
facial photoaging signs over the course of the study (p ≤ 0.05)
vs. marketed products and baseline. However, in both groups,
the rotational products outperformed the marketed products C
and D (Figure 14A). For some parameters, the difference was
seen as early as week 4; by week 12, all parameters showed
greater improvement on the side treated with the rotational
products than the side with the marketed products. These
findings were corroborated by image analysis. The side treated
with the rotational products displayed a significant (p ≤ 0.05)
reduction in crow’s feet wrinkles/lines than the side treated with
marketed products C or D (Figure 14B).
Frontiers in Medicine | www.frontiersin.org 14 September 2021 | Volume 8 | Article 724344
DiNatale et al. Rotational Topical Improves Facial Photoaging
FIGURE 14 | Clinical trial #3 results. (A) Clinical efficacy study results of rotational treatment vs. two commercial products. Clinical grading results show reduction
(improvement) in photoaging parameters at different timepoints when compared to baseline scores and when the rotational regimen (A + B) is compared to marketed
products (C or D). An asterisk indicates a statistically significant difference between the rotational regimen and product C or D (p < 0.05). (B) Crow’s feet wrinkle
image analysis of clinical efficacy study results of rotational treatment vs. two commercial products. Image analysis result shows reduction (improvement) in wrinkle
parameters at the crow’s feet area at different timepoints when compared to baseline values. Differences between the rotational regimen (A + B) vs. marketed
products (C or D) were statistically significant at all three time points shown here (*p < 0.05).
DISCUSSION
The hypothesis that applying multiple antiaging ingredients in a
rotational or alternating regimen to address facial photodamage
signs originates from our confirmed theory that the effect on
skin of a single active ingredient, such as retinol, may plateau
over time. Therefore, this hypothesis was systematically tested
in a multi-tiered approach using in vitro, ex vivo, and in vivo
studies. Results presented herein show that a decreasing rate of
improvement, or the plateau effect, can indeed be reduced with a
novel “rotational” regimen of active ingredients.
Retinol is a well-accepted, efficacious ingredient (23–25)
shown to have long-term efficacy (26); however, sustaining the
rate of improvement has not been demonstrated. In order to
identify a more effective treatment approach, active ingredients
were tested in different application regimens in vitro. We found
that a sequential application of phytol and retinol stimulated
a higher-level production of collagen from human dermal
fibroblasts. PGA and retinol pair was further confirmed ex
vivo. One reason for this enhancement in efficacy may be that
retinol acts in skin after conversion to retinoic acid, which
in turn activates retinoid X receptor (RXR) and retinoic acid
receptor (RAR) (27), while phytol is converted to phytanic acid,
which has been shown to be a ligand of not only RXR but
also peroxisome proliferator-activated receptors (PPARs) (28).
Due to their receptor binding specificities, retinol and phytol
can be viewed as not only competing but also complementary
ingredients. Although glycolic acid can provide an additional
skin barrier and renewal benefit (29), it is difficult to formulate
together with retinol due to specific formula pH restrictions
(unpublished own data). Therefore, glycolic acid was added to the
phytol formula in order to obtain the maximum possible efficacy
and benefit from all three ingredients.
When the effect of those formulations on human skin
were assessed in vivo through patch application followed by
skin biopsy, rotational application of a PGA-based formula
and a retinol formula showed enhanced or at least similar
results compared to continuous single treatment as measured
by multiple skin markers. The biopsies used for RS analysis
showed the effect of rotational actives on dermal structure post-
application. Indeed, subtle changes were recognizable within
each layer of the treated skin samples, as demonstrated by
alterations in relevant peak formation and attenuation. Band
assignments to these changes and ratios allowed for correlation
with clinical and histological findings (30–32), demonstrating
significant increases in residues of collagen and collagen
content for the rotational treatment compared to untreated
samples. Interestingly, the band at 1,160 cm−1 representing
GAG content was also significantly increased in the rotational
samples compared to the untreated group. These findings
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further corroborate histological increases in pro-collagen I
and HABP.
Clinical testing of the aforementioned regimen in vivo used
a weekly rotational application of a PGA-based formula and
a retinol-based formula. Two randomized, double-blind, IRB-
approved, controlled clinical trials were conducted to test the
efficacy of this regimen. The application of the rotational
cosmetic regimen over the course of 1 year resulted in continued
improvement in facial photoaging signs without a plateau effect.
Comparing the rotational regimen to marketed products, the
rotational regimen sustained greater improvement over the
course of 6 months and showed long-lasting benefits during the
2-month regression period.
Our findings here, for the first time, identify a novel approach
for a skin regimen that can produce long-lasting antiaging effects.
Our rotational application strategy has some advantages over
combination treatments alone including continued enhanced
efficacy throughout the 12-month study duration. It avoids
the need to make a single product containing all active
ingredients, as some may not be compatible for formulation
or lead to undesirable side effects. It also simplifies product
usage each day to one product, although keeping track of
product rotation may require help from additional application,
packaging, or delivery apparatus. Overall, this strategy may
provide a faster, more effective venue for new developments in
cosmetic antiaging products.
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